Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease
, 2001 Carl E Clarke, Katherine Deane
openalex +2 more sources
Pathological Gambling Associated With Cabergoline Therapy in a Patient With a Pituitary prolactinoma. [PDF]
, 2007 M.W.J. Davie
openalex +1 more source
publicité directement auprès du consommateur/patient - Antagonistes de la dopamine et problèmes valvulaires cardiaques - pergolide, cabergoline - nanofibres - trastuzumab - Existe-t-il une association? [PDF]
, 2007 Die Redaktion
openalex +1 more source
A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease [PDF]
, 1987 Allolio, B. +4 more
core +1 more source
Cabergoline, a Hopeful Medicine for Prolactinomas and Non-tumoral Hyperprolactinemia
, 2001 Nobuhiro Miki
openalex +2 more sources
ND3: COST-EFFECTIVENESS OF CABERGOLINE COMPARED TO LEVODOPA IN EARLY PARKINSON'S DISEASE IN SWEDEN
, 2001 Peter Lindgren, Björn Jonsson
openalex +1 more source
Increased Prevalence of Tricuspid Regurgitation in Patients with Prolactinomas Chronically Treated with Cabergoline [PDF]
, 2008 Annamaria Colao +9 more
openalex +1 more source
Secondary Loss of Response to Dopamine Receptor Agonists in the Treatment of Macroprolactinoma. [PDF]
CureusAlkundi A, Momoh R.
europepmc +1 more source
Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism [PDF]
, 2008 Celia Larramendy +5 more
openalex +1 more source